OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gasdermin E: A Prospective Target for Therapy of Diseases
Xiu-Xiu Liao, Yongzhao Dai, Yaozhong Zhao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Procyanidin B2 Mitigates Methotrexate-Induced Hepatic Pyroptosis by Suppressing TLR4/NF-κB and Caspase-3/GSDME Pathways
Juman Alsaab, Wedad S. Sarawi, Ahlam M. Alhusaini, et al.
Food and Chemical Toxicology (2025), pp. 115341-115341
Closed Access | Times Cited: 2

Cancer-associated pyroptosis: A new license to kill tumor
Qing Kong, Zhibin Zhang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27

Gasdermins: a dual role in pyroptosis and tumor immunity
Jiayi Yang, Jingting Jiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

Plasma-activated saline hyperthermic perfusion-induced pyroptosis boosts peritoneal carcinomatosis immunotherapy
Qi Miao, Xinyi Zhao, Runze Fan, et al.
Free Radical Biology and Medicine (2025)
Closed Access | Times Cited: 1

NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Wen Xu, Yi Huang, Rongbin Zhou
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 1

The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Junhan Liang, Zhirong Wan, Cheng Qian, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7

Caspase-3/GSDME mediated pyroptosis: A potential pathway for sepsis
Chaoze Jiao, Haidan Zhang, Hongyao Li, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111022-111022
Closed Access | Times Cited: 13

Inhibition of ROS/caspase-3/GSDME-mediated pyroptosis alleviates high glucose-induced injury in AML-12 cells
Xinrui Wang, Shengying Ye, Linge Tong, et al.
Toxicology in Vitro (2024) Vol. 98, pp. 105840-105840
Closed Access | Times Cited: 4

Pyroptosis: a new therapeutic strategy in cancer
Meltem Tuncer, Simay Alcan
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6191-6200
Closed Access | Times Cited: 10

Systemic Administration of Ra-223 Dichloride: A Nonclinical Study
Jin Young Baik, Yiseul Choi, Eun Sang Lee, et al.
(2025)
Closed Access

Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy
Mojtaba Tarin, Amir Sh. Saljooghi
Biochemical Pharmacology (2025), pp. 116961-116961
Closed Access

Mitochondria-Derived Vesicles, Sterile Inflammation, and Pyroptosis in Liver Cancer: Partners in Crime or Innocent Bystanders?
Flora Guerra, Francesca Romana Ponziani, Ferdinando Cardone, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4783-4783
Open Access | Times Cited: 3

Insight into the structure, function and the tumor suppression effect of gasdermin E
Yuge Long, Xiaoyuan Jia, Liang Chu
Biochemical Pharmacology (2024) Vol. 226, pp. 116348-116348
Closed Access | Times Cited: 3

Mitochondrial Quality Control Processes at the Crossroads of Cell Death and Survival: Mechanisms and Signaling Pathways
Emanuele Marzetti, Riccardo Calvani, Francesco Landi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7305-7305
Open Access | Times Cited: 3

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue
Julia Nowowiejska, Anna Baran, Anna Pryczynicz, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2149-2149
Open Access | Times Cited: 8

Maresin1 alleviates neuroinflammation by inhibiting caspase-3/ GSDME-mediated pyroptosis in mice cerebral ischemia-reperfusion model
Maoji Zhao, Wenjing Xian, Wenyi Liu, et al.
Journal of Stroke and Cerebrovascular Diseases (2024) Vol. 33, Iss. 8, pp. 107789-107789
Open Access | Times Cited: 2

The Role and Therapeutic Potential of Pyroptosis in Colorectal Cancer: A Review
Qing Fang, Yunhua Xu, Xiangwen Tan, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 874-874
Open Access | Times Cited: 2

Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2

Caspase‐3/GSDME‐mediated pyroptosis leads to osteogenic dysfunction of osteoblast‐like cells
Zhixiao Wu, Qian Ding, Muxin Yue, et al.
Oral Diseases (2023) Vol. 30, Iss. 3, pp. 1392-1402
Closed Access | Times Cited: 3

SIRT1 Inhibition-Induced Mitochondrial Damage Promotes GSDME-Dependent Pyroptosis in Hepatocellular Carcinoma Cells
Di Liu, Junhao Liu, Kejun Liu, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 12, pp. 3628-3639
Open Access | Times Cited: 1

[Splicing mutations of
Danyang Li, Hongyang Wang, Qiuju Wang
PubMed (2024) Vol. 38, Iss. 1, pp. 30-37
Closed Access

Cisplatin induces acute liver injury by triggering caspase-3/GSDME-mediated cell pyroptosis
Ping-Ping Wu, Xiujin Shen, Shusen Zheng
Hepatobiliary & pancreatic diseases international (2024)
Closed Access

Drug Repurposing Patent Applications July–September 2024
Hermann AM Mucke
Assay and Drug Development Technologies (2024)
Closed Access

Engineering single‐domain antibodies targeting Gasdermin E activation by the chemotherapeutic agent cis‐diaminodichloroplatinum
Jinyi Ma, Jintao Xu, Qiuyun Gao, et al.
Biotechnology Journal (2023) Vol. 18, Iss. 9
Closed Access

Page 1 - Next Page

Scroll to top